300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Oman
Romania
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Sagin Capital & Consulting, VC Fund

Sagin Capital & Consulting

VC Fund

Saga, Japan

Sagin Capital & Consulting is a VC fund in Saga focused on Information Technology and Artificial Intelligence. Sagin Capital & Consulting is the venture capital arm of The Bank of Saga.

Total investments:
38
Last investment:
Lead investor:
13%
Fund size:
$4.7M
Last fund:

Last updated:

Industries Sagin Capital & Consulting invests in

Information TechnologyArtificial IntelligenceInternetSoftwareFood and Beverage

Stages Sagin Capital & Consulting invests in

Venture - Series UnknownSeries BSeries ASeedSeries C

Countries Sagin Capital & Consulting invests in

Japan

Round sizes

Series A $2M–$5.7MSeries B $2.4M–$14MVenture - Series Unknown $117k–$6.4M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Series A
$2M–$5.7M
Series B
$2.4M–$14M
Venture - Series Unknown
$117k–$6.4M

Investment Focus

Industry

  • Information Technology 8 (21%)
  • Artificial Intelligence 6 (16%)
  • Internet 4 (11%)
  • Software 4 (11%)
  • Food and Beverage 4 (11%)
See all 73 industries →

Stage

  • Venture - Series Unknown 16 (42%)
  • Series B 9 (24%)
  • Series A 4 (11%)
  • Seed 3 (8%)
  • Series C 1 (3%)
See all 8 stages →

Team

NameTitleInvestmentsLinksEmail
Naoto Shimoeda Representative Director
Representative Director Total investments: 2 Find email

Investments

CompanyDescriptionRoundLinks
Medteria is a medtech startup developing pathology AI. It is the provider of the “Medteria” communication cloud platform for healthcare professionals and medical students. $651.4K / Venture - Series Unknown / Sep 10, 2026
KUZEN provides enterprise-grade chatbot technologies, especially the bot framework and NLP, via a visual UI without coding. The company is utilizing technology to develop a system that broadens the scope of dialogue. They use technology to provide their customers with next-generation standard procedures that broaden the possibilities ofconversation, resulting in unprecedented business practices. Secondary Market / Jul 07, 2026
KUZEN provides enterprise-grade chatbot technologies, especially the bot framework and NLP, via a visual UI without coding. The company is utilizing technology to develop a system that broadens the scope of dialogue. They use technology to provide their customers with next-generation standard procedures that broaden the possibilities ofconversation, resulting in unprecedented business practices. $10.1M / Series B / Jul 07, 2026
EUV Photon is an irradiation services company that conducts processing, evaluation, and measurement of materials for EUV lights. $5.4M / Seed / Jun 29, 2026
KLD KLD
KLD is an online store that sells and purchases used clothing and accessories, as well as reuse system development services. Venture - Series Unknown / Dec 26, 2025
CI Partners mission is to "eliminate the word 'disability' from this country," and with the message "Everyone is a star." $2.6M / Series B / Dec 18, 2025
Surv Biopharma develops a drug discovery platform that facilitates research and development of veterinary drugs and pharmaceutical products. $14.1M / Series B / Nov 11, 2025
Coco is a communication tool. They develop software that will help the service sector become more customer-oriented. They improve customer satisfaction by digitizing customer surveys and converting telephone interactions with customers to text chat. $2M / Series A / Oct 21, 2025
Trustart engages in real estate research business and real estate big data provision. The company offers real estate big data and big data subscriptions. $6.8M / Venture - Series Unknown / Aug 07, 2025
KAICO is a pharmaceuticals, diagnostic drugs production company. $3.8M / Series B / Apr 15, 2025
See all 38 investments →

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Oil and Gas
Film
Retail
Payments
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Social Network
Blockchain
B2B
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Software
Renewable Energy
Crowdfunding
Venture Capital
Social
Infrastructure
Beauty
Fashion
Climate
LGBT
Cannabis
Celebrity
Life Science
Food and Beverage
Publishing
Mobile Apps
Wine and Spirits
Music
Art
Real Estate
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Transportation
Enterprise
Community
Media (Entertainment)
Recruiting
Web3
Medical
Theatre
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Brazil
LATAM
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Oman
Romania
Poland
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Czech Republic
Costa Rica
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Moldova
Botswana
Seychelles
Paraguay
Canada
South Africa
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
Ireland
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Sagin Capital & Consulting invest in?

Sagin Capital & Consulting invests primarily in Information Technology, Artificial Intelligence and Internet startups, most often at Venture - Series Unknown and Series B stage. Most of the 38 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What is Sagin Capital & Consulting's check size?

Sagin Capital & Consulting typically joins rounds of $2M–$5.7M at Series A, $2.4M–$14M at Series B and $117k–$6.4M at Venture - Series Unknown. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sagin Capital & Consulting participates in.

How do I contact Sagin Capital & Consulting?

Public channels for Sagin Capital & Consulting include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Sagin Capital & Consulting?

The team at Sagin Capital & Consulting includes Naoto Shimoeda (Representative Director). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Sagin Capital & Consulting Sagin Capital & Consulting Find emails